Correction: Cardiotoxicity following thoracic radiotherapy for lung cancer

Gerard M Walls^{1

2}, Carmen Bergom^{3

4}, Joshua D Mitchell⁵, Stacey L Rentschler^{6

7}, Geoffrey D Hugo^{3

4}, Pamela P Samson^{3

4}, Clifford G Robinson^{3

4}

Affiliations

¹ Department of Radiation Oncology, Washington University in St Louis, Saint Louis, MO, USA. g.walls@qub.ac.uk.
² Patrick Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, NI, USA. g.walls@qub.ac.uk.
³ Department of Radiation Oncology, Washington University in St Louis, Saint Louis, MO, USA.
⁴ Siteman Cancer Center, Washington University Medical Campus, Saint Louis, MO, USA.
⁵ Cardio-Oncology Center of Excellence, Washington University in St Louis, St Louis, MO, USA.
⁶ Department of Developmental Biology, Washington University in St Louis, St. Louis, MO, USA.
⁷ Center for Cardiovascular Research, Department of Medicine, Cardiovascular Division, Washington University in St Louis, St. Louis, MO, USA.

Published Erratum

Gerard M Walls et al. Br J Cancer. 2025 Mar.

. 2025 Mar;132(4):401-407.

doi: 10.1038/s41416-024-02926-x.

Gerard M Walls^{1

2}, Carmen Bergom^{3

4}, Joshua D Mitchell⁵, Stacey L Rentschler^{6

7}, Geoffrey D Hugo^{3

4}, Pamela P Samson^{3

4}, Clifford G Robinson^{3

4}

¹ Department of Radiation Oncology, Washington University in St Louis, Saint Louis, MO, USA. g.walls@qub.ac.uk.
² Patrick Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, NI, USA. g.walls@qub.ac.uk.
³ Department of Radiation Oncology, Washington University in St Louis, Saint Louis, MO, USA.
⁴ Siteman Cancer Center, Washington University Medical Campus, Saint Louis, MO, USA.
⁵ Cardio-Oncology Center of Excellence, Washington University in St Louis, St Louis, MO, USA.
⁶ Department of Developmental Biology, Washington University in St Louis, St. Louis, MO, USA.
⁷ Center for Cardiovascular Research, Department of Medicine, Cardiovascular Division, Washington University in St Louis, St. Louis, MO, USA.

No abstract available

Erratum for

Cardiotoxicity following thoracic radiotherapy for lung cancer.
Walls GM, Bergom C, Mitchell JD, Rentschler SL, Hugo GD, Samson PP, Robinson CG. Walls GM, et al. Br J Cancer. 2025 Mar;132(4):311-325. doi: 10.1038/s41416-024-02888-0. Epub 2024 Nov 6. Br J Cancer. 2025. PMID: 39506136 Free PMC article. Review.

1. Schytte T, Hansen O, Stolberg-Rohr T, Brink C. Cardiac toxicity and radiation dose to the heart in definitive treated non-small cell lung cancer. Acta Oncol. 2010;49:1058–60. 10.3109/0284186X.2010.504736 - PubMed
1. Han CB, Wang WL, Quint L, Xue JX, Matuszak M, Ten Haken R, et al. Pulmonary artery invasion, high dose radiation, and overall survival in patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014;89:313 10.1016/J.IJROBP.2014.02.011 - PMC - PubMed
1. Tucker SL, Liu A, Gomez D, Tang LL, Allen P, Yang J, et al. Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation. Radiother Oncol. 2016;119:495–500. 10.1016/J.RADONC.2016.04.025 - PubMed
1. Speirs CK, DeWees TA, Rehman S, Molotievschi A, Velez MA, Mullen D, et al. Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer. J Thorac Oncol.2017;12:293–301. 10.1016/J.JTHO.2016.09.134 - PubMed
1. Vivekanandan S, Landau DB, Counsell N, Warren DR, Khwanda A, Rosen SD, et al. The impact of cardiac radiation dosimetry on survival after radiation therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;99:51–60. 10.1016/j.ijrobp.2017.04.026 - PMC - PubMed